Introduction
Targeting tumor angiogenesis for specific drug transfer into tumor masses and metastasis has been identified as a promising approach for three main reasons: i) angiogenesis is a common and genetically stable characteristic of most solid tumors, ii) it is readily accessible from the blood stream and iii) it can be targeted by specific RGD-containing peptides binding integrin . This integrin is indeed poorly
expressed on quiescent vessels and is selectively overexpressed on activated endothelial cells of growing vessels. In addition, integrin α v β 3 is also frequently overexpressed on tumor cells, as observed in lung cancers , , melanomas , brain tumors or breast cancers .
[4] [5] Integrins are membrane-spanning heterodimers of and subunits, both of which comprise a short cytoplasmic tail, a single α β transmembrane helix and a large extracellular domain . Most integrins are expressed in a default low-affinity ligand-binding state but [6] their conformation and affinity can vary in response to cellular and microenvironment stimulations , . This will also affect their lateral [7 8 ] assembly and clustering on the surface of the cell . Several groups have developed multimeric RGD-presenting molecules, with the aim [9] not only to increase integrin affinity and clustering but also to induce an active integrin-mediated internalization . [10] [11] [12] We have developed a Regioselectively Addressable Functionalized Template (RAFT) cyclo-decapeptide scaffold, able to present 4 cyclic RGD pentapeptide motifs. We have shown using nuclear or optical imaging methods, that RAFT-RGD allows an improved and α v β 3 -specific targeting and drug delivery as well as imaging of tumors as compared to the monomeric cyclic RGD (cRGD) . [13] in vivo [14] [15] [16] [17] 2 11
Surprisingly, while the interaction between RGD-ligands and integrins has been known for a long time , and RGD-containing [18 19 ] molecules been widely used to deliver various kinds of cargos including nanoparticles (liposomes or polymers), cytotoxic peptides, low molecular weight drugs and contrast-enhancing agents (fluorochromes, radiotracers) , , very little is known about the [12 [20] [21] [22] internalization mechanism of RGD peptides binding to integrin .
Two studies have described how an antibody directed against integrin (mAb 17E6) and monomeric or multimeric RGD peptides
are internalized. Both concluded that the internalization of monomeric RGD ligands is independent of its receptor and occurs via a α v β 3 fluid-phase endocytic pathway. In contrast, multimeric RGD molecules are co-internalized with their receptor , , evidence in favor of [23 24] integrin aggregation and clustering.
The integrin endo/exocytic cycle suggests that there are, at least, three types of pathways associated with integrin [25] [26] [27] internalization: 1/clathrin-mediated endocytosis was described for integrins ; 2/caveolae-mediated endocytosis for integrins [29] and 3/clathrin-caveolae-independent endocytosis. To our knowledge, endocytosis of integrins was described to occur through
clathrin-dependent endocytosis or uncoated vesicles . Clathrin-dependent endocytosis has also been described for viruses such as [30] [ 31] adenoviruses that enter the cells after binding to the integrin secondary receptor .
Here, we studied the biological properties of the tetrameric RAFT-RGD peptide (coupled or not to fluorescent probes) as compared to those of its monomeric counterpart cRGD so as to better understand and improve the potential of RGD-based vectors to specifically deliver therapeutic drugs directly inside the target cells. We measured their affinity (K ) for the purified integrin in solution. to free RAFT-RAD-Cy5. The K of RAFT-RGD-Cy5 was also determined for a non-specific receptor integrin : in this case, the D α 3 β 1 measured K was 1147 nM, 300 fold higher than the one obtained with .
RAFT-RGD slows down integrin mobility in the cell membrane
We measured the mobility of integrin in the membrane of adherent HEK293( ) cells in the presence of the different peptides by
FRAP analysis using a confocal microscope. These cells expressing natural amount of the human chain were stably transfected with a α v plasmid encoding for the human chain. We focused the laser beam on the apical membrane for two reasons: 1/integrins from this region
are mobile because they are not engaged in cell-matrix adhesions and 2/this area is less affected by cell shrinkage usually observed in the presence of RGD peptides. Adherent cells were co-incubated for 8 min with the different peptides and the R-PhycoErythrin-labeled LM609 antibody. After the RPE photobleaching in a defined area (ROI), the time for fluorescence recovery due to the lateral movement of RPE-labeled integrins on the membrane was measured ( ). Importantly, we initially verified that LM609 s binding was not affected by 
RAFT-RGD can bind two
integrins simultaneously
In order to confirm the data obtained by FRAP, we aimed at visualizing the possible formation of integrin clusters induced by RAFT-RGD. We used negative staining electron microscopy to observe integrin and /RGD-peptides mixed in 1 mM Mg /Ca
as illustrated in . Peptides were used in excess as compared to the integrin concentration. These conditions are not supposed to Fig. 3 maximize the number of dimers. Integrins alone or mixed with cRGD or RAFT-RAD displayed compact particles representing single heterodimers of RGD as expected. Indeed, the monomeric cRGD does not have the possibility to interact with several integrins at
the same time, while the RAFT-RAD is not able to recognize them at all. Conversely /RAFT-RGD micrographs were frequently
showing larger particles corresponding to complexes of two integrins probably linked by the multimeric RAFT-RGD. Visually, we
estimated that about 10 of /RAFT-RGD were forming integrin dimers. But, this percentage was most probably underestimated
because we counted only the aggregates laying on the grid in a proper angle of examination and providing particles with this typical dimer-shape. For example, clusters viewed down the long axis would appear more compact and were not included (the staining agent [33] outlines only those parts of the objects that are in contact with the carbon film). Nevertheless, electron microscopy is a qualitative technique and not a quantitative technique: dimers of integrins may bind with less affinity to the carbon than monomeric integrins, thus leading to underestimate the number of dimers.
RAFT-RGD-mediated integrin internalization
RAFT-RGD-Cy5 and cRGD-Cy5 internalizations were observed by confocal microscopy on live HEK293( ) cells ( ). RAFT-RGD-Cy5 was rapidly internalized in small vesicles after 10 min ( ) but was also found in the cytoplasm and at cell-cell Fig. 4a contacts. Monomeric cRGD-Cy5 internalization is less extensive than that of RAFT-RGD-Cy5 and the laser intensity had to be increased three times in order to obtain comparable signal intensities ( ).
Fig. 4E
We then developed a special ELISA assay to demonstrate that RGD-peptides were inducing integrin internalization. Briefly,
integrins exposed on the surface of HEK293( ) cells were biotinylated and the cells were incubated in the presence of 0 to 1 M 
10 min ( ). In the presence of RAFT-RGD, internalization increased in a dose-dependent manner and reached 21 2 at 1 M, Table 1 ± % μ corresponding to an increase of 79 control. In contrast, increasing doses of cRGD (from 0.1 to 4 M) did not affect integrin % vs. μ internalization at all, which remained similar to that of the control ( . 12 1 at 1 M). Altogether this indicated that RAFT-RGD i.e ± % μ internalization was correlated with integrin endocytosis, while the monomeric cRGD did not affect natural endocytosis.
RAFT-RGD internalization occurs via clathrin-mediated endocytosis
RAFT-RGD-Cy5 and cRGD-Cy5 internalization pathways were analyzed using confocal microscopy in the presence of specific inhibitors ( ). In the presence of the clathrin-inhibitor amantadine at 1 mM ( ), RAFT-RGD-Cy5 internalization was extensively ). In the presence of 1 mM amiloride, internalization of the peptides remained unchanged ( Fig. 4c and 4g Fig . 4d ) although, we proved by using 70 kDa-dextran-FITC, that macropinocytose was correctly inhibited in these cells (data not shown). and 4h
These results were confirmed by the ELISA measurements of the integrin amount internalized after binding to RAFT-RGD in the
presence of amantadine, nystatin or amiloride ( ). In the presence of amantadine, 1 M of RAFT-RGD was not able any more to Table 1 μ induce integrin internalization and the of internalized integrins was exactly similar to the control values (12 2 ). In contrast, nystatin
or amiloride did not prevent RAFT-RGD-induced integrin internalization. These data suggested that RAFT-RGD was internalized
with integrin via the clathrin-dependent pathway. Furthermore, peptides internalization was quantified from confocal microscopy
analysis. The related peptide internalization indexes are reported (mean of Cy5-intensity/pixels). Those indexes confirmed that Figure 4 RAFT-RGD internalization occurred in a clathrin-dependent pathway, but also that RAFT-RGD gets into the cells more efficiently than cRGD.
Discussion
Drug vectorization mediated by specific tumor-targeting molecules could allow specific delivery of cytotoxic agents to tumors therefore limiting their systemic toxicity. Based on this concept, RGD-containing peptides have been largely used for the targeting of α v β 3 -integrin expressing tumors and/or of their microvasculature. Our group contributed to the development of a synthetic multimeric RGD-based vector, called RAFT-RGD. This peptide proved to be particularly efficient for the delivery of drugs, imaging agents or both [ , , . However, although RGD-integrin interaction has been discovered a long time ago , , the mechanism of 14-16 17 34 ] [18 19] internalization of monomeric or multimeric RGD peptides is a poorly documented process. In this study, we focused our attention to the study of the mechanism by which the well-known cRGD, similar to the original cyclic peptide developed by Kessler et al.
, and its [35 42 ] these factors being known to switch integrins in their high affinity state. In addition, it must be noticed that previous measurements of the K described in the literature were based on solid-phase receptor binding assays. In our case, integrins were in solution and this certainly D modified their constant of affinity.
Using FRAP, we also demonstrated that the multimeric RAFT-RGD decreased the lateral mobility of receptors on the surface of
HEK293( ) cells. This suggested that the presence of four cRGD motifs onto the RAFT scaffold allowed the clustering of integrin .
This result is important because it suggested at least two cRGD motifs presented by a single RAFT molecule can bind two integrins. This was an open challenge for the RAFT scaffold, which is no more than 10 large. Indeed, the three-dimensional structure of purified
integrin showed that the diameter of this integrin is close to 100 , but that the RGD binding site is on the periphery of the molecule.
The 2 RGD motifs presented by a single RAFT could thus bridge 2 integrins positioned back to back. This was confirmed by EM results, which indicated that the tetrameric, but not the monomeric cRGD, could form clusters of 2 integrins. Formation of these clusters was
then immediately followed by an active internalization of the tetrameric RAFT-RGD-Cy5 via, and concomitantly with integrin .
Indeed, the natural endocytosis of this integrin almost doubled in less than 10 min in the presence of RAFT-RGD and its internalization was mainly involving clathrin-mediated endocytosis. Accordingly, this process was abolished in the presence of amantadine, a specific inhibitor of the clathrin-mediated endocytosis. Macropinocytosis and caveolae-mediated endocytosis may not be implicated since their inhibitors like amiloride or nystatin had no effect on RAFT-RGD internalization. Interestingly, the monomeric cRGD peptide interacted in a completely different manner. Its internalization did not rely on clathrin-or caveolae-mediated endocytosis and was most probably independent of because of the internalization of the integrin which was not affected. These results are in agreement with a previous α v β 3 report and indicated that cRGD can probably cross cell membranes via a fluid-phase pathway . The corresponding efficiency of [24] internalization is however much less efficient than that of the RAFT-RGD, which explains the lower intensity of staining of the inside of cells labeled with cRGD-Cy5 and as demonstrated by the indexes in . Figure 4 Viruses such as foot-and-mouth disease virus or adenovirus present several RGD motifs allowing their interaction with the
integrin. This interaction is a prerequisite to their internalization , , which also occurs via clathrin-coated vesicles . RAFT-RGD [32 44 ] [45] may thus mimic some properties of these viruses.
In summary, the tetrameric RAFT-RGD binds 10 times more strongly to its receptor than cRGD. RAFT-RGD is actively and
efficiently internalized with integrin via clathrin-coated pits as previously described for the integrin . This contrasts with the α v β 3 α v β 3 [46] trafficking route followed by the integrin, which was shown to use preferentially a caveolae-dependent pathway . Efficient β 1 [47] internalization is of course an important issue for drug delivery and we proved that this RAFT-RGD molecule is indeed capable of inducing a specific and efficient targeted intracellular delivery of a toxic peptide able to destabilize mitochondria . [13] From this study, multimeric presentation of cRGD motifs appears to be a prerequisite for the development of efficient integrin targeting and cell internalizing vectors for drug delivery to tumors.
Materials and Methods

Material
Integrin was purchased from Chemicon International (CC1021, St Quentin en Yvelines, France). Monoclonal antibody
anti-human integrin LM609 conjugated to R-PhycoErythrin (RPE-LM609) and anti-human CD61 were purchased from Chemicon 
RGD-Peptides Synthesis and Fluorescent Labeling
Compounds were synthetized according to previously reported procedures and chemical structures are presented in .
[34] peptide were grafted via an oxime bond (R1-O-N C-R2) for recognition of the integrin . On the other side of the RAFT, either Cy5
mono NHS (N-hydroxysuccinimide) ester (Amersham Biosciences, Uppsala, Sweden) or FITC (Sigma-Aldrich, St Quentin Fallavier, France) was added on the lysine chain (c -KKKPGKAKPG-) . As a negative control probe, Cy5-labeled RAFT(c -R ADfK-)
(RAFT-RAD) was also synthesized in a similar way.
FCS analysis
FCS study was performed on the ConfoCor 2 system (Carl Zeiss, Jena, Germany) using a 40 water immersion C-Apochromat − for a good fit). Furthermore, the residual curves had no wavy shape (see example in ). supplementary data
Cell Lines and Culture Conditions
HEK293( ), stable transfectants of human from the human embryonic kidney cell line (kindly provided by J-F. Gourvest, Aventis,
France), were cultured as described in Jin et al. . The cell line was cultured at 37 C in a humidified 95 air/5 CO atmosphere. 
Electron microscopy
Soluble human integrin (Chemicon, CC1021) was diluted to 0.095 mg/ml ( 3.65 fmol) in PBS containing MgCl and CaCl at 1
mM and mixed with RAFT-RGD 0.45 mg/ml ( 1 nmol), cRGD 0.1 mg/ml ( 1 nmol) or RAFT-RAD 0.45 mg/ml ( 1 nmol) for 2 min
before addition on top of a carbon-coated electron microscope grid. Thirty sec later, the excess of liquid was removed by blotting with a filter paper. Four ml of a 2 Uranyl Acetate solution were placed on the grid and incubated for 30 sec 1 min at room temperature. The % -staining solution was subsequently removed by filter paper adsorption, and the grid was dried on a paper filter for 2 min and then examined using an electron microscope. Micrographs were taken under low-dose conditions with a Jeol 1200-EX II microscope at 100 kV or a FEI CM12 microscope at 120 kV and a respectively calibrated magnification of 40000 and 45000 times. Selected negatives films were digitalized on a Zeiss scanner (Photoscan TD) with a pixel size of 14 mm, corresponding to 3.5 or 3.1 at the sample scale. . Depending of the [50] condition, cells were kept at 4 C or placed 10 min at 37 C in DMEM alone (control) or containing RAFT-RGD or cRGD from 0.1 to 4 °°μ M, in order to allow receptor internalization.
In order to measure endocytosis inhibition, amantadine 1 mM, nystatin 1 M or amiloride 1mM were added to the medium 30 min μ before biotin labeling. Those inhibitors were kept in the medium during biotin labeling and peptides internalization. Representative examples of negatively stained electron micrographs of the soluble integrin alone or mixed with RGD-peptides. The
integrins remain in monomeric state except when using RAFT-RGD; in this condition, integrins can be found as dimers on the grid. As expected, RGD-peptides (<6 kDa) were not distinguishable. Upper panels: Original images. Lower panels: Photoshop enhanced visualization of the complexes.
Figure 4
Confocal imaging on HEK293( ) living cells vs. a Variations of internalization were compared to the control condition (absence of peptide). Results were expressed as mean / S.E.M. and each experiment was performed in quadruplet at least. 
